KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 141 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $653,000 | +50.5% | 119,526 | +24.3% | 0.02% | +21.1% |
Q2 2022 | $434,000 | +101.9% | 96,131 | +230.3% | 0.02% | +90.0% |
Q1 2022 | $215,000 | -84.9% | 29,108 | -86.8% | 0.01% | -88.6% |
Q4 2021 | $1,420,000 | +573.0% | 220,875 | +510.1% | 0.09% | +417.6% |
Q3 2021 | $211,000 | -16.6% | 36,201 | +47.5% | 0.02% | -19.0% |
Q2 2021 | $253,000 | -29.5% | 24,542 | -28.1% | 0.02% | -36.4% |
Q1 2021 | $359,000 | -36.2% | 34,151 | -6.2% | 0.03% | -45.0% |
Q4 2020 | $563,000 | -30.3% | 36,400 | -14.6% | 0.06% | +7.1% |
Q2 2020 | $808,000 | +700.0% | 42,639 | +152.2% | 0.06% | +522.2% |
Q2 2019 | $101,000 | -30.8% | 16,907 | -32.3% | 0.01% | -10.0% |
Q1 2019 | $146,000 | -27.0% | 24,987 | +112.8% | 0.01% | -28.6% |
Q2 2018 | $200,000 | -51.9% | 11,743 | -62.1% | 0.01% | -51.7% |
Q1 2018 | $416,000 | +105.9% | 31,017 | +38.8% | 0.03% | -47.3% |
Q2 2017 | $202,000 | -26.0% | 22,348 | -23.0% | 0.06% | +27.9% |
Q4 2016 | $273,000 | -48.4% | 29,007 | -27.3% | 0.04% | -8.5% |
Q4 2015 | $529,000 | – | 39,900 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 4,767,078 | $80,993,000 | 5.22% |
Palo Alto Investors LP | 4,663,324 | $79,230,000 | 3.17% |
DOHENY ASSET MANAGEMENT /CA | 282,945 | $4,807,000 | 2.61% |
Private Capital Advisors, Inc. | 416,900 | $7,083,000 | 2.22% |
Sandia Holdings, LLC | 119,739 | $2,034,000 | 0.91% |
Virtus ETF Advisers LLC | 44,986 | $764,000 | 0.68% |
Birchview Capital, LP | 50,000 | $850,000 | 0.58% |
Schonfeld Strategic Advisors LLC | 415,600 | $7,061,000 | 0.38% |
EMERALD ADVISERS, LLC | 561,317 | $9,537,000 | 0.36% |
Kazazian Asset Management, LLC | 20,672 | $351,000 | 0.32% |